U2 snRNP B'', also known as splicing factor U2 auxiliary factor 65 kDa subunit (U2AF65), is a protein that plays a critical role in the pre-mRNA splicing process. It is encoded by the U2AF2 gene in humans. U2AF65 is a component of the U2 small nuclear ribonucleoprotein (snRNP), which is essential for the recognition and removal of introns from pre-mRNA transcripts.The protein functions by binding to the polypyrimidine tract, a sequence of nucleotides located near the 3' splice site of introns. This binding facilitates the recruitment of other splicing factors and the assembly of the spliceosome, a large and dynamic complex responsible for catalyzing the splicing reactions. Through its role in spliceosome assembly, U2AF65 is involved in defining the boundaries between exons and introns, ensuring that splicing occurs precisely and that the resulting mRNA is correctly processed for translation into proteins.
U2AF65 contains two RNA recognition motifs (RRMs) that are responsible for its interaction with RNA, as well as a C-terminal domain that interacts with other splicing factors, such as U2AF35 and the SF1/mBBP protein. These interactions are vital for the stabilization of the early spliceosomal complex and the accurate recognition of splice sites.Mutations or dysregulation of U2AF65 have been linked to various human diseases, including cancer, where aberrant splicing events can lead to the production of oncogenic protein isoforms. The study of U2AF65 and its interaction with other splicing factors is therefore not only fundamental to our understanding of gene expression regulation but also has significant implications for the development of strategies targeting splicing in disease contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Spliceosome inhibitor, binds to SF3B complex within the spliceosome, potentially affecting U2 snRNP B'' function in RNA splicing. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Another inhibitor of the spliceosome, targeting the SF3B complex, which could indirectly influence U2 snRNP B'' activity in splicing. | ||||||
Lomeguatrib | 192441-08-0 | sc-362764 sc-362764A | 10 mg 50 mg | $205.00 $865.00 | ||
Inhibits splicing by targeting the spliceosome, possibly influencing U2 snRNP B'' function. | ||||||
Docetaxel | 114977-28-5 | sc-201436 sc-201436A sc-201436B | 5 mg 25 mg 250 mg | $87.00 $332.00 $1093.00 | 16 | |
A natural product with spliceosome-inhibiting activity, potentially affecting U2 snRNP B'' and RNA splicing. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
A bioflavonoid that inhibits splicing, potentially affecting U2 snRNP B'' by impacting spliceosome function. | ||||||
Madrasin | 374913-63-0 | sc-507563 | 100 mg | $750.00 | ||
Spliceosome inhibitor, potentially influencing the function of U2 snRNP B'' in RNA splicing. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits mRNA splicing, potentially affecting U2 snRNP B'' activity within the spliceosome. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known for antimalarial properties, but can affect RNA processing and potentially influence spliceosome function and U2 snRNP B'' activity. | ||||||